These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9696405)

  • 1. Is the potent 5-HT1A receptor agonist, alnespirone (S-20499), affecting dopaminergic systems in the rat brain?
    Dugast C; Soulière F; Schmitt P; Casanovas JM; Fattaccini CM; Mocaër E; Lesourd M; Renaud B; Artigas F; Hamon M; Chouvet G
    Eur J Pharmacol; 1998 Jun; 350(2-3):171-80. PubMed ID: 9696405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain.
    Casanovas JM; Vilaró MT; Mengod G; Artigas F
    J Neurochem; 1999 Jan; 72(1):262-72. PubMed ID: 9886078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the selective 5-HT1A agonists alnespirone (S-20499) and 8-OH-DPAT on extracellular 5-hydroxytryptamine in different regions of rat brain.
    Casanovas JM; Lésourd M; Artigas F
    Br J Pharmacol; 1997 Oct; 122(4):733-41. PubMed ID: 9375971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
    Protais P; Lesourd M; Comoy E
    Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postsynaptic 5-hydroxytryptamine(1A) receptor activation increases in vivo dopamine release in rat prefrontal cortex.
    Sakaue M; Somboonthum P; Nishihara B; Koyama Y; Hashimoto H; Baba A; Matsuda T
    Br J Pharmacol; 2000 Mar; 129(5):1028-34. PubMed ID: 10696105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatodendritic 5-HT(1A) autoreceptors mediate the anti-aggressive actions of 5-HT(1A) receptor agonists in rats: an ethopharmacological study with S-15535, alnespirone, and WAY-100635.
    de Boer SF; Lesourd M; Mocaër E; Koolhaas JM
    Neuropsychopharmacology; 2000 Jul; 23(1):20-33. PubMed ID: 10869883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo comparison of two 5-HT1A receptors agonists alnespirone (S-20499) and buspirone on locus coeruleus neuronal activity.
    Astier B; Lambás Señas L; Soulière F; Schmitt P; Urbain N; Rentero N; Bert L; Denoroy L; Renaud B; Lesourd M; Muñoz C; Chouvet G
    Eur J Pharmacol; 2003 Jan; 459(1):17-26. PubMed ID: 12505530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic alnespirone-induced desensitization of somatodendritic 5-HT1A autoreceptors in the rat dorsal raphe nucleus.
    Le Poul E; Laaris N; Doucet E; Fattaccini CM; Mocaër E; Hamon M; Lanfumey L
    Eur J Pharmacol; 1999 Jan; 365(2-3):165-73. PubMed ID: 9988099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo.
    Hjorth S; Pettersson G
    Eur J Pharmacol; 1993 Jul; 238(2-3):357-67. PubMed ID: 7691622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alnespirone and buspirone have anxiolytic-like effects in a conflict procedure in rats by stimulating 5-HT(1A) receptors.
    Cervo L; Munoz C; Bertaglia A; Samanin R
    Behav Pharmacol; 2000 Apr; 11(2):153-60. PubMed ID: 10877120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of 5-HT1A receptors on central noradrenergic activity: microdialysis studies using (+/-)-MDL 73005EF and its enantiomers.
    Hajós-Korcsok E; McQuade R; Sharp T
    Neuropharmacology; 1999 Feb; 38(2):299-306. PubMed ID: 10218872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of apparent pA2 values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats.
    Assié MB; Koek W
    Eur J Pharmacol; 2000 Dec; 409(2):173-7. PubMed ID: 11104831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist. I: Neurochemical and electrophysiological profile.
    Claustre Y; Peretti DD; Brun P; Gueudet C; Allouard N; Alonso R; Lourdelet J; Oblin A; Damoiseau G; Françon D; Suaud-Chagny MF; Steinberg R; Sevrin M; Schoemaker H; George P; Soubrié P; Scatton B
    Neuropsychopharmacology; 2003 Dec; 28(12):2064-76. PubMed ID: 12902994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of 5-HT1B receptors in the regulation of serotonin cell firing and release in the rat brain.
    Adell A; Celada P; Artigas F
    J Neurochem; 2001 Oct; 79(1):172-82. PubMed ID: 11595769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.
    Kidd EJ; Haj-Dahmane S; Jolas T; Lanfumey L; Fattaccini CM; Guardiola-Lemaitre B; Gozlan H; Hamon M
    J Pharmacol Exp Ther; 1993 Feb; 264(2):863-72. PubMed ID: 8094756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]Alnespirone: a novel specific radioligand of 5-HT1A receptors in the rat brain.
    Fabre V; Boni C; Mocaër E; Lesourd M; Hamon M; Laporte AM
    Eur J Pharmacol; 1997 Oct; 337(2-3):297-308. PubMed ID: 9430429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the oxytocin and vasopressin responses to the 5-HT1A agonist and potential anxiolytic drug alnespirone (S-20499).
    Van de Kar LD; Levy AD; Li Q; Brownfield MS
    Pharmacol Biochem Behav; 1998 Jul; 60(3):677-83. PubMed ID: 9678651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of 5-HT(1B/1D) receptors in the mesolimbic dopamine system increases dopamine release from the nucleus accumbens: a microdialysis study.
    Yan QS; Yan SE
    Eur J Pharmacol; 2001 Apr; 418(1-2):55-64. PubMed ID: 11334865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HT1A receptor agonist properties of the antipsychotic, nemonapride: comparison with bromerguride and clozapine.
    Assié MB; Cosi C; Koek W
    Eur J Pharmacol; 1997 Sep; 334(2-3):141-7. PubMed ID: 9369342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.